Symptomtext
patient who is 62 years old and was given fluzone high dose quadrivalent with no reported adverse event; Initial information received on 08-Nov-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (healthcare professional). This case involves a 62 years old male patient who was given Influenza quadrival A-B high dose hv vaccine [Fluzone high-dose quadrivalent] with no reported adverse event . The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 13-Oct-2022, the patient who was 62 received 0.5 ml dose (once) of suspect Influenza quadrival A-B high dose hv vaccine (lot UJ937AB, exp date: 30-Jun-2023) via intramuscular route in the right deltoid for immunistion with no reported adverse event (product administered to patient of inappropriate age) (latency: same day). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.